Eric G. Lovett

3.3k total citations · 1 hit paper
33 papers, 2.4k citations indexed

About

Eric G. Lovett is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Complementary and alternative medicine. According to data from OpenAlex, Eric G. Lovett has authored 33 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 6 papers in Complementary and alternative medicine. Recurrent topics in Eric G. Lovett's work include Heart Rate Variability and Autonomic Control (21 papers), Cardiovascular Syncope and Autonomic Disorders (8 papers) and Cardiac Health and Mental Health (8 papers). Eric G. Lovett is often cited by papers focused on Heart Rate Variability and Autonomic Control (21 papers), Cardiovascular Syncope and Autonomic Disorders (8 papers) and Cardiac Health and Mental Health (8 papers). Eric G. Lovett collaborates with scholars based in United States, Italy and Germany. Eric G. Lovett's co-authors include Richard L. Verrier, Diane R. Gold, Joel Schwartz, Andrew C. Larson, George Allen, Augusto A. Litonjua, Bruce D. Nearing, Jill Schafer, C. Arden Pope and Douglas W. Dockery and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Environmental Health Perspectives.

In The Last Decade

Eric G. Lovett

33 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ambient Pollution and Heart Rate Variability

2000 676 citations Diane R. Gold, Joel Schwartz et al. Circulation profile →

Peers

Countries citing papers authored by Eric G. Lovett

Since Specialization

Citations

This map shows the geographic impact of Eric G. Lovett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric G. Lovett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric G. Lovett more than expected).

Fields of papers citing papers by Eric G. Lovett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric G. Lovett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric G. Lovett. The network helps show where Eric G. Lovett may publish in the future.

Co-authorship network of co-authors of Eric G. Lovett

This figure shows the co-authorship network connecting the top 25 collaborators of Eric G. Lovett. A scholar is included among the top collaborators of Eric G. Lovett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric G. Lovett. Eric G. Lovett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted Hypoglossal Nerve Stimulation for Patients With Obstructive Sleep Apnea 2023 ·JAMA Otolaryngology–Head & Neck Surgery ·Alan R. Schwartz, Ofer Jacobowitz, David W. Eisele, Samuel A. Mickelson, (unknown), Arie Oliven, Victor Certal, Martin L. Hopp, David Winslow, Tod Huntley, Nathan E. Nachlas, Luu V. Pham, M. Boyd Gillespie, (unknown), Eric G. Lovett, John Paul Shen, Atul Malhotra, Joachim T. Maurer	25
2	Design and rationale for the treating Obstructive Sleep Apnea using Targeted Hypoglossal Nerve Stimulation (OSPREY) trial 2022 ·Contemporary Clinical Trials ·Ofer Jacobowitz, Alan R. Schwartz, Eric G. Lovett, (unknown), Atul Malhotra	4
3	An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems 2016 ·Journal of the American Society of Hypertension ·Rolf Wachter, Marcel Halbach, George L. Bakris, John D. Bisognano, Hermann Haller, Joachim Beige, Abraham A. Kroon, Mitra K. Nadim, Eric G. Lovett, Jill Schafer, Peter W. de Leeuw	16
4	Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction 2016 ·Seminars in Thoracic and Cardiovascular Surgery ·Fred A. Weaver, William T. Abraham, William C. Little, Christian Butter, Anique Ducharme, Marcel Halbach, Didier Klug, Eric G. Lovett, Navid Madershahian, Jochen Müller‐Ehmsen, Jill Schafer, Michele Senni, Vijay Swarup, Rolf Wachter, Michael R. Zile	26
5	Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 2016 ·Clinical Research in Cardiology ·Edoardo Gronda, Gianmaria Brambilla, Gino Seravalle, Alessandro Maloberti, Matteo Cairo, Giuseppe Costantino, Eric G. Lovett, Emilio Vanoli, Giuseppe Mancia, Guıdo Grassı	21
6	Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Cardiac Resynchronization Therapy 2015 ·European Journal of Heart Failure ·Michael R. Zile, William T. Abraham, Fred A. Weaver, Christian Butter, Anique Ducharme, Marcel Halbach, Didier Klug, Eric G. Lovett, Jochen Müller‐Ehmsen, Jill Schafer, Michele Senni, Vijay Swarup, Rolf Wachter, William C. Little	67
7	Long-term chronic baroreflex activation 2015 ·Journal of Hypertension ·Edoardo Gronda, Gino Seravalle, Fosca Quarti Trevano, Giuseppe Costantino, Andrea Casini, (unknown), Eric G. Lovett, Emilio Vanoli, Giuseppe Mancia, Guıdo Grassı	35
8	Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction 2015 ·JACC Heart Failure ·William T. Abraham, Michael R. Zile, Fred A. Weaver, Christian Butter, Anique Ducharme, Marcel Halbach, Didier Klug, Eric G. Lovett, Jochen Müller‐Ehmsen, Jill Schafer, Michele Senni, Vijay Swarup, Rolf Wachter, William C. Little	195
9	Chronic Baroreflex Activation Effects on Sympathetic Nerve Traffic, Baroreflex Function, and Cardiac Haemodynamics in Heart Failure: A Proof-of-Concept Study 2014 ·European Journal of Heart Failure ·Edoardo Gronda, Gino Seravalle, Gianmaria Brambilla, Giuseppe Costantino, Andrea Casini, (unknown), Eric G. Lovett, Giuseppe Mancia, Guıdo Grassı	135
10	BAROREFLEX ACTIVATION THERAPY REDUCES HOSPITAL RESOURCE UTILIZATION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION 2014 ·Journal of the American College of Cardiology ·Edoardo Gronda, Giuseppe Costantino, (unknown), (unknown), (unknown), (unknown), (unknown), Emilio Vanoli, Eric G. Lovett, Giuseppe Mancia, Guıdo Grassı	1
11	The Baroreceptor as a Therapeutic Target for Heart Failure 2014 ·Journal of Cardiovascular Translational Research ·Edoardo Gronda, Eric G. Lovett, (unknown), Dimitrios Georgakopoulos, Guıdo Grassı, Emilio Vanoli	10
12	Abstract 16137: Chronic Baroreflex Activation Reduces Sympathetic Tone and Improves Clinical Outcomes in Reduced-Ejection Fraction Heart Failure 2013 ·Circulation ·Edoardo Gronda, Gino Seravalle, Gianmaria Brambilla, Giuseppe Costantino, (unknown), (unknown), Andrea Casini, (unknown), (unknown), Eric G. Lovett, Guıdo Grassı	2
13	Abstract 15273: Baroreflex Activation Therapy Significantly Lowers NTproBNP in Patients with Symptomatic Heart Failure 2012 ·Circulation ·Marcel Halbach, Navid Madershahian, Mathias C. Brandt, Dennis Ladage, (unknown), Eric G. Lovett, Uta C. Hoppe, Jochen Müller‐Ehmsen	2
14	Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial 2012 ·Journal of the American Society of Hypertension ·George L. Bakris, Mitra K. Nadim, Hermann Haller, Eric G. Lovett, Jill Schafer, John D. Bisognano	171
15	Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial 2012 ·Journal of the American Society of Hypertension ·Uta C. Hoppe, Mathias C. Brandt, Rolf Wachter, Joachim Beige, Lars Christian Rump, Abraham A. Kroon, Adam W. Cates, Eric G. Lovett, Hermann Haller	204
16	MINIMALLY-INVASIVE SYSTEM FOR BAROREFLEX ACTIVATION THERAPY CHRONICALLY REDUCES BLOOD PRESSURE: INITIAL RESULTS FROM THE BAROSTIM NEO TRIAL 2012 ·Journal of the American College of Cardiology ·Mathias C. Brandt, Rolf Wachter, Joachim Beige, Hermann Haller, Uta C. Hoppe, Eric G. Lovett, Jill Schafer, Abraham A. Kroon	1
17	Abstract 4850: Improved Myocardial Energetics Following Chronic Treatment Using an Implantable Device in Resistant Hypertension: Results From European and United States Trials of the Rheos ^® System 2009 ·Circulation ·Peter de Leeuw, John D. Bisognano, David S. Bach, Eric G. Lovett, Christopher L. Kaufman	1
18	Advanced Rhythm Discrimination for Implantable Cardioverter Defibrillators Using Electrogram Vector Timing and Correlation 2002 ·Journal of Cardiovascular Electrophysiology ·Michael R. Gold, STEPHEN R. SHOROFSKY, Julie Thompson, Jaeho Kim, Mark D. Schwartz, (unknown), Eric G. Lovett, William Hsu, (unknown), Douglas Lang	41
19	Heart rate variability associated with particulate air pollution 1999 ·American Heart Journal ·C. Arden Pope, Richard L. Verrier, Eric G. Lovett, Andrew C. Larson, Mark Raizenne, Richard E. Kanner, Joel Schwartz, (unknown), Diane R. Gold, Douglas W. Dockery	484
20	Approximate minimum bias multichannel spectral estimation for heart rate variability 1997 ·Annals of Biomedical Engineering ·Eric G. Lovett, Joel B. Myklebust	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact